Cardura and Hypertriglyceridaemia - a phase IV clinical study of FDA data

Summary:

Hypertriglyceridaemia is reported as a side effect among people who take Cardura (doxazosin mesylate), especially for people who are male, 60+ old, also take Signifor Lar, and have Acromegaly.

The phase IV clinical study analyzes which people have Hypertriglyceridaemia when taking Cardura. It is created by eHealthMe based on reports of 20,021 people who have side effects when taking Cardura from the FDA, and is updated regularly.

What is Cardura?

Cardura has active ingredients of doxazosin mesylate. It is often used in high blood pressure. eHealthMe is studying from 20,379 Cardura users. Check the latest studies of Cardura.

What is Hypertriglyceridaemia?

Hypertriglyceridaemia (excess of triglycerides in the blood) is found to be associated with 754 drugs and 763 conditions by eHealthMe. Check the latest studies of Hypertriglyceridaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

20,021 people reported to have side effects when taking Cardura.
Among them, 14 people (0.07%) have Hypertriglyceridaemia.

Could Cardura cause Hypertriglyceridaemia?

Among these 14 people:

What is the gender of people who have Hypertriglyceridaemia when taking Cardura? *

female: 14.29 %
male: 85.71 %

What is the age of people who have Hypertriglyceridaemia when taking Cardura? *

What are other drugs people take besides Cardura? *

What are other side effects people have besides Hypertriglyceridaemia? *

High Blood Cholesterol: 7 people, 50.00%
Cardiac Failure Congestive: 4 people, 28.57%
Hypotension (abnormally low blood pressure): 3 people, 21.43%
Atrioventricular Block (heart block): 3 people, 21.43%
Rashes (redness): 3 people, 21.43%
Hyperglycemia (high blood sugar): 3 people, 21.43%
Fatigue (feeling of tiredness): 3 people, 21.43%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 21.43%
Diabetes: 3 people, 21.43%
Chest Pain: 2 people, 14.29%

What are the existing conditions these people have? *

Rickets (softening of bones): 3 people, 21.43%
Primary Hypothyroidism (failure of the thyroid gland to produce or release thyroid hormones into the bloodstream): 3 people, 21.43%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 3 people, 21.43%
Joint Pain: 2 people, 14.29%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 7.14%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 7.14%
High Blood Cholesterol: 1 person, 7.14%
Gastric Disorder (disease of stomach): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Cardura and have Hypertriglyceridaemia?

- Check whether Hypertriglyceridaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cardura:

Cardura (20,379 reports)

Browse all side effects of Cardura:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypertriglyceridaemia:

Hypertriglyceridaemia (754 drugs)

Browse all the conditions that are associated with Hypertriglyceridaemia:

Hypertriglyceridaemia (763 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on doxazosin mesylate (the active ingredients of Cardura) and Cardura (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.